Chronic eosinophilic leukaemia in blast crisis in a cat negative for feline leukaemia virus

S. Toth,A. Nash,A. McEwan,O. Jarrett

DOI: https://doi.org/10.1136/VR.117.18.471

1985-11-02

Abstract:

What problem does this paper attempt to address?

Nanoparticle formulations as recrystallization inhibitors in transdermal patches

Muhammad Azam Tahir,Mohamed Ehab Ali,Alf Lamprecht

DOI: https://doi.org/10.1016/j.ijpharm.2019.118886

2020-02-15

Abstract:Drug crystallization in transdermal patches is still a major challenge, confronting the formulation development of topical drug delivery systems. Encapsulation of drugs into nanoparticles is proposed here as a promising tool for regulating drug crystallization in transdermal patches. The degree of recrystallization and transdermal permeation of ibuprofen and hydrocortisone loaded in polymeric and lipid nanoparticles from matrix-type transdermal patches were investigated. Ethyl cellulose (EC4), poly (lactide-co-glycolic acid) (PLGA) and polycaprolactone (PCL) were employed for polymeric nanoparticle preparations; while medium chain triglyceride (MCT) and witepsol were used for the preparation of MCT nanoemulsion and solid lipid nanoparticles (SLNs), respectively. As control, similar patches were prepared containing the free form of the investigated model drugs. All nanoparticle-containing transdermal patches exhibited less degree of drug recrystallization after 4 weeks compared to the control groups. Among the investigated nanocarriers, transdermal patches formulated with drug-loaded lipid nanoparticles showed the lowermost degree of recrystallization. Drug encapsulation into SLNs succeeded to reduce the degree of ibuprofen and hydrocortisone recrystallization from 23.3 ± 0.9 and 21.9 ± 1.2% to 0.2 ± 0.1 and 1.8 ± 0.1%, respectively. Additionally, the decreased crystalline fraction was accompanied by a corresponding increase in the drug flux through excised pig skin, which was found to be correlated to the hydrophobicity of the different nanocarriers. In conclusion, polymeric and lipid nanoparticles proved to be effective tools for the preparation of transdermal patches with on-demand drug loadings, while lowering the recrystallization risks. Moreover, the results of this study can be a valuable guidance for the design of effective transdermal patches by controlling the crystallization of various drugs through fine tuning of the carrier hydrophobicity.
Transdermal Delivery of Curcumin-Loaded Solid Lipid Nanoparticles as Microneedle Patch: an In Vitro and In Vivo Study

Ankitha Prabhu,Jobin Jose,Lalit Kumar,S Salwa,M Vijay Kumar,Seyed Mohammad Nabavi

DOI: https://doi.org/10.1208/s12249-021-02186-5

IF: 3.3

2022-01-05

AAPS PharmSciTech

Abstract:Curcumin is well known for its neuroprotective effect, and also able to alleviate Parkinsonian features. Clinical application of curcumin is limited due to its low bioavailability. Hence, we hypothesized that the microneedles (MN) containing drug-loaded solid lipid nanoparticles (SLNs) may be able to improve its bioavailability and efficacy. The SLNs were prepared with microemulsion technique using glyceryl monostearate as a lipid and tween 80 as a stabilizer. The particle size, polydispersity index, zeta potential, and entrapment efficiency of prepared SLNs were determined. The optimized formulation was incorporated into microneedle arrays using micromolding technique and fabricated microneedle patch were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, optical microscopy, ex vivo permeation studies, histology studies, and fluorescent microscopy. The fabricated microneedle patch was also evaluated for neuroprotective activity and skin irritation potential. Fourier transform infrared spectroscopy studies of SLNs and microneedles confirmed the chemical compatibility of excipients with curcumin. The developed microneedles were also found to be non-irritant with decreased degree of bradykinesia, high motor coordination, and balance ability. The study provided a theoretical basis for the use of novel microneedle containing curcumin-loaded solid lipid nanoparticles as a useful tool for the treatment of Parkinson's disease.
Formulation and Characterization of Ethyl Cellulose-Based Patches Containing Curcumin-Chitosan Nanoparticles for the Possible Management of Inflammation via Skin Delivery

Asif Nawaz,Muhammad Shahid Latif,Muhammad Khurshid Alam Shah,Tarek M. Elsayed,Saeed Ahmad,Hamid Ali Khan

DOI: https://doi.org/10.3390/gels9030201

IF: 4.6

2023-03-07

Gels

Abstract:Curcumin, a natural phenolic compound, exhibits poor absorption and extensive first pass metabolism after oral administration. In the present study, curcumin-chitosan nanoparticles (cur-cs-np) were prepared and incorporated into ethyl cellulose patches for the management of inflammation via skin delivery. Ionic gelation method was used for the preparation of nanoparticles. The prepared nanoparticles were evaluated for size, zetapotential, surface morphology, drug content, and % encapsulation efficiency. The nanoparticles were then incorporated into ethyl cellulose-based patches using solvent evaporation technique. ATR-FTIR was used to study/assess incompatibility between drug and excipients. The prepared patches were evaluated physiochemically. The in vitro release, ex vivo permeation, and skin drug retention studies were carried out using Franz diffusion cells and rat skin as permeable membrane. The prepared nanoparticles were spherical, with particle size in the range of 203–229 nm, zetapotential 25–36 mV, and PDI 0.27–0.29 Mw/Mn. The drug content and %EE were 53% and 59%. Nanoparticles incorporated patches are smooth, flexible, and homogenous. The in vitro release and ex vivo permeation of curcumin from nanoparticles were higher than the patches, whereas the skin retention of curcumin was significantly higher in case of patches. The developed patches deliver cur-cs-np into the skin, where nanoparticles interact with skin negative charges and hence result in higher and prolonged retention in the skin. The higher concentration of drug in the skin helps in better management of inflammation. This was shown by anti-inflammatory activity. The inflammation (volume of paw) was significantly reduced when using patches as compared to nanoparticles. It was concluded that the incorporation of cur-cs-np into ethyl cellulose-based patches results in controlled release and hence enhanced anti-inflammatory activity.

polymer science
A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery

Praveen Kolimi,Sagar Narala,Ahmed Adel Ali Youssef,Dinesh Nyavanandi,Narendar Dudhipala

DOI: https://doi.org/10.7150/ntno.77395

2023-01-01

Nanotheranostics

Abstract:Recent advances in drug delivery technologies utilizing a variety of carriers have resulted in a paradigm shift in the current approach to diagnosis and therapy. Mesoporous silica nanoparticles (MSNs) were developed in response to the need for materials with high thermal, chemical, and mechanical properties. The synthesis, ease of surface functionalization, tunable pore size, large surface area, and biocompatibility of MSNs make them useful in a variety of biomedical applications such as drug delivery, theranostics, and stem cell research. In addition, MSNs have a high capability of delivering actives ranging from small molecules such as drugs and amino acids to larger peptides, vaccines, and antibodies in general. Moreover, MSN-based transdermal delivery has sparked a lot of interest because of the increase in drug stability, permeation, and ease of functionalization. The functionalization of MSNs plays an important role in the efficient delivery of therapeutic agents in a highly controlled manner. This review introduced dermal and transdermal drug delivery systems, explained the anatomy of the skin, and summarized different barriers that affect the transdermal delivery of many therapeutic agents. In addition, the fundamentals of MSNs together with their physicochemical properties, synthesis approaches, raw materials used in their fabrication, and factors affecting their physicochemical properties will be covered. Moreover, the applications of MSNs in dermal and transdermal delivery, the biocompatibility of MSNs in terms of toxicity and safety, and biodistribution will be explained with the help of a detailed literature review. The review is covering the current and future perspectives of MSNs in the pharmaceutical field with therapeutic applications.
Role of the carboxyl terminus in stable expression of hamster UDP-GlcNAc:dolichol-P GlcNAc-1-P transferase.

J. Zara,M. Lehrman

IF: 5.485

1994-07-22

Journal of Biological Chemistry

Abstract:In order to examine the function of the carboxyl terminus of UDP-GlcNAc:dolichol-P GlcNAc-1-P transferase (GPT), an endoplasmic reticulum enzyme that synthesizes GlcNAc-P-P-dolichol and, thus, catalyzes the committed step for N-linked glycosylation, a series of carboxyl-terminal truncation mutations was examined. Removal of the last 11 amino acids (398-408) from GPT had no significant effect on catalytic activity, thermal stability, tunicamycin binding, reticular localization, or consumption of cellular dolichol-P. However, in the absence of residues 398-408, the removal of three additional residues (Phe395-Ser396-Ile397), or their change to Leu395-Met396-Trp397 fully eliminated enzyme expression in vivo. By reattaching residues 398-408 to Leu395-Met396-Trp397, expression was restored. Thus, the carboxyl-terminal region of GPT is essential for stable expression. Either of two sequences (395-397 and 398-408) is sufficient for expression, but neither is necessary. Expression of GPT in the absence of residues 398-408 specifically required the Phe395-Ser396-Ile397 sequence, since most scramble and termination mutations within this sequence were inhibitory. One scramble mutant (Ile395-Ser396-Phe397-Stop398) was enzymatically active, but unusually thermolabile. Thus, the function of Phe395-Ser396-Ile397 may be to stabilize GPT.
Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study

Indrajit Ghosh,Bozena Michniak-Kohn

DOI: https://doi.org/10.1208/s12249-013-9995-4

IF: 3.3

AAPS PharmSciTech

Abstract:In transdermal drug delivery systems, it is always a challenge to achieve stable and prolonged high permeation rates across the skin since the concentrations of the drug dissolved in the matrix have to be high in order to maintain zero order release kinetics. Several attempts have been reported to improve the permeability of poorly soluble drug compounds using supersaturated systems. However, due to thermodynamic challenges, there was a high tendency for the drug to nucleate immediately after formulating or even during storage. The present study focuses on the efficiency of nanoparticles and influence of different concentrations of solubilizer such as vitamin E TPGS (D-a-tocopheryl polyethylene glycol 1000 succinate) to improve the permeation rate through the skin. Effects of several formulation factors were studied on the nanosuspension systems using ibuprofen as a model drug. The overall permeation enhancement process through the skin was influenced mostly by the solubilizer and also by the size of nanoparticles. The gel formulation developed with vitamin E TPGS + HPMC nanosuspension, consequently represent a promising approach aiming to improve the permeability performance of a poorly water soluble drug candidate.
Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol

DOI: https://doi.org/10.2147/ijn.s452207

IF: 7.033

2024-05-07

International Journal of Nanomedicine

Abstract:Aguo Cheng, 1, 2 Suohui Zhang, 1, 3 Fanda Meng, 4 Mengzhen Xing, 5 Han Liu, 3 Guozhong Yang, 3 Yunhua Gao 1– 3 1 Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry of Chinese Academy of Sciences, Beijing, People's Republic of China; 2 University of Chinese Academy of Sciences, Beijing, People's Republic of China; 3 Beijing CAS Microneedle Technology Ltd, Beijing, People's Republic of China; 4 School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong Province, People's Republic of China; 5 Key Laboratory of New Material Research Institute, Department of Pharmaceutical Research Institute, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, People's Republic of China Correspondence: Yunhua Gao, Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry of Chinese Academy of Sciences, Beijing, People's Republic of China, Tel +86 (10)82543581, Email Purpose: Transdermal Drug Delivery System (TDDS) offers a promising alternative for delivering poorly soluble drugs, challenged by the stratum corneum's barrier effect, which restricts the pool of drug candidates suitable for TDDS. This study aims to establish a delivery platform specifically for highly lipophilic drugs requiring high doses (log P > 5, dose > 10 mg/kg/d), to improve their intradermal delivery and enhance solubility. Methods: Cannabidiol (CBD, log P = 5.91) served as the model drug. A CBD nanosuspension (CBD-NS) was prepared using a bottom-up method. The particle size, polydispersity index (PDI), zeta potential, and concentration of the CBD-NS were characterized. Subsequently, CBD-NS was incorporated into dissolving microneedles (DMNs) through a one-step manufacturing process. The intradermal dissolution abilities, physicochemical properties, mechanical strength, insertion depth, and release behavior of the DMNs were evaluated. Sprague-Dawley (SD) rats were utilized to assess the efficacy of the DMN patch in treating knee synovitis and to analyze its skin permeation kinetics and pharmacokinetic performance. Results: The CBD-NS, stabilized with Tween 80, exhibited a particle size of 166.83 ± 3.33 nm, a PDI of 0.21 ± 0.07, and a concentration of 46.11 ± 0.52 mg/mL. The DMN loaded with CBD-NS demonstrated favorable intradermal dissolution and mechanical properties. It effectively increased the delivery of CBD into the skin, extended the action's duration in vivo, and enhanced bioavailability. CBD-NS DMN exhibited superior therapeutic efficacy and safety in a rat model of knee synovitis, significantly inhibiting TNF-α and IL-1β compared with the methotrexate subcutaneous injection method. Conclusion: NS technology effectively enhances the solubility of the poorly soluble drug CBD, while DMN facilitates penetration, extends the duration of action in vivo, and improves bioavailability. Furthermore, CBD has shown promising therapeutic outcomes in treating knee synovitis. This innovative drug delivery system is expected to offer a more efficient solution for the administration of highly lipophilic drugs akin to CBD, thereby facilitating high-dose administration. Keywords: nanosuspension, highly lipophilic drugs, dissolving microneedle, cannabidiol, knee synovitis Graphical The poor solubility of many current drugs and drug candidates presents a significant challenge within the pharmaceutical industry. 1 Approximately 40% of recently marketed drug compounds exhibit limited solubility in water, complicating their development and production processes. 2,3 The low solubility often leads to reduced dissolution rates, adversely affecting the bioavailability and absorption of orally administered drugs. 4,5 To exploit the therapeutic potential of poorly soluble drugs, several solubility enhancement strategies are employed, including nanoparticle systems, solubilization with cosolvents and surfactants, amorphous forms, solid dispersions, cocrystals, polymeric micelles, inclusion complexes, pH adjustments, salt forms, and liposomes. 6,7 Beyond mere solubilization, research is increasingly directed toward advanced delivery systems aimed at not only improving the bioavailability of poorly soluble agents but also enhancing patient compliance. 8 These systems address issues such as frequent dosing, swallowing difficulties, and needle phobia, offering controlled, targeted, or regulated delivery. Among these, the transdermal drug delivery system -Abstract Truncated-

pharmacology & pharmacy,nanoscience & nanotechnology
Dissolvable microneedles for transdermal drug delivery showing skin pentation and modified drug release

Irina Iachina,André H Eriksson,Malene Bertelsen,Karsten Petersson,Jörgen Jansson,Pernille Kemp,Karen M Engell,Jonathan R Brewer,Kim T Nielsen

DOI: https://doi.org/10.1016/j.ejps.2023.106371

2023-03-01

Abstract:Topical therapies for chronic skin diseases suffer from a low patient compliance due to the inconvenient treatment regimens of available products. Dissolvable microneedles (MN) with modified release offer an interesting possibility to increase the compliance by acting as a depot in the skin and thereby decreasing the dosing frequency. Furthermore, the bioavailability can be increased significantly by bypassing the barrier of the skin by the direct penetration of the MN into the skin. In this study the depot effect and skin penetration of an innovative dissolvable MN patch was assessed by insertion in ex vivo human skin and in vivo using minipigs. The MN patches are based on biodegradable polymers and the active pharmaceutical ingredients calcipotriol (Calci) and betamethasone-17-21-dipropionate (BDP) used to treat psoriasis. Using computed tomography (CT) and Coherent anti-Stokes Raman scattering (CARS) microscopy it was possible to visualize the skin penetration and follow the morphology of the MN as function of time in the skin. The depot effect was assessed by studying the modified in vitro release in an aqueous buffer and by comparing the drug release of a single application of a patch both ex vivo and in vivo to daily application of a marketed oleogel containing the same active pharmaceutical ingredients. The CT and CARS images showed efficient penetration of the MN patches into the upper dermis and a slow swelling process of the drug containing tip over a period of 8 days. Furthermore, CARS demonstrated that it can be used as a noninvasive technique with potential applicability in clinical settings. The in vitro release studies show a release of 54% over a time period of 30 days. The pharmacological relevance of MNs was confirmed in human skin explants and in vivo after single application and showed a similar response on calcipotriol and BDP mediated signaling events compared to daily application of the active oleogel. Altogether it was demonstrated that the MN can penetrate the skin and have the potential to provide a depot effect.
Self-Nanoformulating Poly(2-oxazoline) and Poly(2-oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study

Robert Luxenhofer,Hélder Santos,Carmine D´Amico,Anna-Lena Ziegler,Giuseppina Molinaro,Marianna Kemell

DOI: https://doi.org/10.26434/chemrxiv-2024-72j6j

2024-05-24

Abstract:Here, we introduce a pioneering approach in the domain of transdermal drug delivery systems (TDDS) by using microneedles (MNs) fabricated from amorphous solid dispersion comprising only a model drug and an amphiphilic block copolymer to form a drug nanoformulation upon MN dissolution. This approach presents the most minimalistic approach to maximize drug loading in MN, reaching 40 wt.%. Using scanning electron microscopy, we carefully examined the morphology of MNs across a spectrum of drug loading ratios, revealing a remarkable consistency in structure and integrity. Mechanical testing confirms the MNs' proficiency in effective skin penetration. Furthermore, a comparative study on the formation of polymeric micelles underscores the innovative concept of a “nano-in-micro drug delivery system”, offering an approach to drug release. The results demonstrate that MNs manufactured from an amorphous solid dispersion of drug and amphiphilic block copolymer with ultra-high loading, enhancing the availability and release dynamics of hydrophobic drugs, positioning them as a potent tool for enhancing TDDS. This study sets a new benchmark in the utilization of polymer-drug nanoformulations for transdermal applications and underscores the exceptional capacity for high drug loading and the creation of adaptable drug delivery mechanisms for the studied amphiphilic block copolymer.

Chemistry
Porous microneedle arrays as promising tools for the quantification of drugs in the skin: a proof of concept study

Eyman M Eltayib,Achmad Himawan,Usanee Detamornrat,Wildan Khairi Mukhtadi,Huanhuan Li,Luchi Li,Lalitkumar Vora,Ryan F Donnelly,Eyman M. Eltayib,Wildan Khairi Muhtadi,Ryan F. Donnelly

DOI: https://doi.org/10.1080/10837450.2024.2319734

2024-03-06

Pharmaceutical Development and Technology

Abstract:This study aimed to demonstrate the potential of using porous microneedles (PMNs) as a promising tool for the noninvasive quantification of topically applied pharmaceutical products. We fabricated a porous microneedle (PMN) from a blend of cellulose acetate and dimethyl sulfoxide by casting and phase separation; it was characterized using scanning electron microscopy, Raman spectroscopy, differential scanning calorimetry, and a Texture Analyzer. An ex vivo study was conducted as a proof-of-concept study to assess whether this PMN could be used to quantify drug absorption through the skin after the topical administration of two nonequivalent products of sodium ibuprofen (gel and dissolving microneedles). Three cellulose acetate formulations (PMN1: 37.5%, PMN-2: 44.4%, and PMN-3: 50%) were used to prepare PMN patches; subsequently, these were evaluated for their morphological and insertion properties. Only PMN-2 microneedle patches were chosen to continue with the ex vivo study. The ex vivo study results demonstrated that PMNs could absorb and release sodium ibuprofen (SDIB) and differentiate between two different SDIB topical products. This can be attributed to the porous and interconnected architecture of these microneedles. This developmental study highlights the potential success of such a tool for the quantification of dermal drug concentration and supports moving to in vivo tests.

pharmacology & pharmacy
Is the male Aicardi's characterized by 46 XXY karyotype?

S. Saddichha

DOI: https://doi.org/10.1016/j.jns.2009.03.032

2009-09-15

Journal of Neurological Sciences

Abstract:
Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.

Yiyun Cheng,Na Man,Tongwen Xu,Rongqiang Fu,Xueyuan Wang,Xiaomin Wang,Longping Wen

DOI: https://doi.org/10.1002/jps.20745

IF: 3.8

2007-01-01

Journal of Pharmaceutical Sciences

Abstract:Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most frequently used drugs in the world, primarily for symptoms associated with osteoarthritis and other chronic musculoskeletal conditions. However, adverse effects caused by oral administration, such as local or systemic disturbance in the gastrointestinal tract, have limited the clinical applications of these drugs. In the present study we have assessed the ability of polyamidoamine (PAMAM) dendrimers to facilitate transdermal delivery of NSAIDs, using Ketoprofen and Diflunisal as model drugs. In vitro permeation studies with excised rat skins indicated that PAMAM dendrimers significantly enhanced the accumulative permeated amount of both drugs after 24 h, as compared to drug suspensions without PAMAM dendrimers. Similarly, anti-nociceptive studies using the acetic acid-induced writhing model in mice showed a prolonged pharmacodynamic profile for the NSAIDs–PAMAM dendrimer complex after transdermal administration. In addition, blood drug level studies revealed that the bioavailability was 2.73 times higher for the Ketoprofen–PAMAM dendrimer complex and 2.48 times higher for the Diflunisal–PAMAM dendrimer complex, respectively, than the pure drug suspensions. These results demonstrated that PAMAM dendrimers can effectively facilitate skin penetration of NSAIDs and may have the potential applications for the development of new transdermal formulations.
Development of Piroxicam loaded SLN-based Hydrogel for Transdermal Delivery

Vinod Kumar Verma,Ram Alpana

DOI: https://doi.org/10.37285/ijpsn.2014.7.1.4

2014-02-28

International Journal of Pharmaceutical Sciences and Nanotechnology

Abstract:The aim of present study was to construct and investigate the efficacy of solid lipid nanoparticles (SLNs) based hydrogel for transdermal delivery of non-steroidal anti-inflammatory drug (NSAID) piroxicam. Solid lipid nanoparticles (SLNs) of piroxicam were produced by solvent emulsification diffusion method in a solvent saturated system. The SLNs were composed of tripalmitin lipid, polyvinyl alcohol (PVA) as stabilizer, and solvent ethyl acetate. All the formulations were subjected to particle size analysis, zeta potential, drug entrapment efficiency, percent drug loading determination and in-vitro release studies. The SLNs formed were in nano-size range with maximum entrapment efficiency of 88.50±0.92. Further, Carbopol-934 was used as a gel matrix for preparation of hydrogel for improving the penetration rate across the skin and viscosity of piroxicam loaded SLNs for transdermal drug administration. The drug release behaviors from piroxicam loaded SLNs based hydrogel exhibited long duration and constant rate of drug release over 24 hr. Skin penetration of piroxicam loaded SLNs based hydrogel was assessed by confocal laser scanning microscopy (CLSM).

English Else
Effect of HEC (Hydroxyethyl Cellulose) Polymer on Nanoemulsion-Based Curcumin Transdermal Patch Release

Rahmatia Is. Kaluku,Robert Tungadi,Nur Ain Thomas

DOI: https://doi.org/10.37311/ijpe.v2i3.12025

2022-08-29

Indonesian Journal of Pharmaceutical Education

Abstract:Curcumin a hydrophobic polyphenolic compound and water-insoluble that creates low systemic bioavailability inside the body, has broad pharmacological activity, including anti-inflammation. This study aims to formulate, characterize and evaluate the nanoemulsion based on curcumin through an in vitro transdermal patch preparation. This study starts from formulating a curcumin nanoemulsion solution and characterizing the particle size of curcumin through PSA (Particle Size Analyzer). Further, it formulates the transdermal patch preparation with the smallest curcumin particles within three concentrations (HEC 0,625%, 1,25%, and 2,5%) combined with HPMC 2,5% as polymer. Those formulations are evaluated through organoleptic, thickness, weight uniformity, humidity, and folding resistance tests. In the next step, this study examines the penetration through an in vitro by using a franz diffusion cell within 72 hours. The result shows increasing penetration on each formula where the best penetrations occur in the 15th and 24th hours. It also discovers that the formula containing HEC 2,5% (2c) creates the highest cumulative drug penetration (15,83%). Therefore, it deduces that curcumin nanoemulsion in the transdermal patch has good characteristics and is compatible between drug and polymer.
Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems

Jeanri Myburgh,Wilna Liebenberg,Clarissa Willers,Admire Dube,Minja Gerber

DOI: https://doi.org/10.3390/pharmaceutics15102413

IF: 6.525

2023-10-04

Pharmaceutics

Abstract:The aim was to assess the suitability of three nano-based transdermal drug delivery systems containing ibuprofen: a nano-emulsion, a nano-emulgel, and a colloidal suspension with ibuprofen-loaded nanoparticles. Understanding the transdermal delivery of ibuprofen using nano-based drug delivery systems can lead to more effective pain relief and improved patient compliance. Characterization tests assessed the suitability of the developed drug delivery systems. Membrane release and skin diffusion studies, along with tape stripping, were performed to determine drug release and skin permeation of ibuprofen. In vitro cytotoxicity studies on HaCaT cells were conducted using MTT and neutral red assays to evaluate the safety of the developed drug delivery systems. Characterization studies confirmed stable drug delivery systems with ideal properties for transdermal delivery. Membrane release studies demonstrated the successful release of ibuprofen. In vitro skin diffusion experiments and tape stripping, detecting ibuprofen in the receptor phase, stratum corneum-epidermis, and epidermis-dermis, indicating successful transdermal and topical delivery. The in vitro cytotoxicity studies observed only minor cytotoxic effects on HaCaT cells, indicating the safety of the developed drug delivery systems. The investigation demonstrated promising results for the transdermal delivery of ibuprofen using the developed drug delivery systems, which contributes to valuable insights that may lead to improved pain management strategies.

pharmacology & pharmacy
Nanosuspension-Based Drug Delivery Systems for Topical Applications

Mohamed Aldeeb,Gofarana Wilar,Cecep Suhandi,Khaled Elamin,Nasrul Wathoni

DOI: https://doi.org/10.2147/ijn.s447429

IF: 7.033

2024-01-26

International Journal of Nanomedicine

Abstract:Mohamed Mahmud E Aldeeb, 1, 2, &ast Gofarana Wilar, 3, &ast Cecep Suhandi, 1, &ast Khaled M Elamin, 4, &ast Nasrul Wathoni 1, &ast 1 Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia; 2 Department of Pharmaceutics, Faculty of Pharmacy, Elmergib University, Alkhoms, 40414, Libya; 3 Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia; 4 Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan &astThese authors contributed equally to this work Correspondence: Nasrul Wathoni, Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia, Tel +62-22-842-888-888, Email Nanosuspensions have garnered recent attention as a promising strategy for mitigating the bioavailability challenges of hydrophobic drugs, particularly those characterized by poor solubility in both aqueous and organic environments. Addressing solubility issues associated with poorly water-soluble drugs has largely resolved the need to enhance drug absorption and bioavailability. As mucosal formulations and topical administration progress in the future, nanosuspension drug delivery, straightforward formulation techniques, and versatile applications will continue to be subjects of interest. Nanosuspensions have undergone extensive scrutiny in preparation for topical applications, encompassing ocular, pulmonary, and dermal usage. Among the numerous methods aimed at improving cutaneous application, nanocrystals represent a relatively recent yet profoundly intriguing approach. Despite the increasing availability of various nanosuspension products, primarily designed for oral administration, only a limited number of studies have explored skin permeability and drug accumulation in the context of nanosuspensions. Nevertheless, the scant published research unequivocally underscores the potential of this approach for enhancing cutaneous bioavailability, particularly for active ingredients with low to medium solubility. Nanocrystals exhibit increased skin adhesiveness in addition to heightened saturation solubility and dissolution rate, thereby augmenting cutaneous distribution. The article provides a comprehensive overview of nanosuspensions for topical application. The methodology employed is robust, with a well-defined experimental design; however, the limited sample size raises concerns about the generalizability of the findings. While the results demonstrate promising outcomes in terms of enhanced drug delivery, the discussion falls short of addressing certain limitations. Additionally, the references largely focus on recent studies, but a more diverse inclusion of historical perspectives could offer a more holistic view of the subject. Keywords: nanosuspension, nanotechnology, topical, dermal Over the past two decades, there has been a notable emergence of cutting-edge advancements in the realm of pharmaceutical research and development. The automation of the drug discovery process, facilitated by technologies such as high-throughput screening, combinatorial chemistry, and computer-aided drug design, has resulted in the generation of a substantial array of highly effective drug candidates. 1 Regrettably, a considerable proportion of these promising medications grapple with the challenge of low water solubility, with approximately 40% of drugs in the developmental pipeline encountering solubility issues. 2,3 High-throughput screening techniques have contributed to the identification of an increasing number of drugs exhibiting limited water solubility. The constrained solubility of these compounds poses a significant impediment during the initial phases of screening for pharmacological activity, as well as throughout the formulation development and clinical testing processes. 4 Preparing one of these substances for preclinical investigations and pharmacological activity assessments is a prerequisite well in advance of their commercialization. 5 Consequently, it becomes evident that the adoption of innovative technical strategies is imperative to augment the bioavailability of drugs characterized by low solubility. The predominant challenge faced by the pharmaceutical industry resides in the development of novel formulation procedures and drug delivery technologies tailored to effectively address the solubility limitations associated with therapeutic candidates. These concerns frequently intersect with issues pertaining to low oral bioavailability. 6–8 To atta -Abstract Truncated-

pharmacology & pharmacy,nanoscience & nanotechnology
NIR-responsive transdermal delivery of atenolol based on polyacrylamide-modified MoS2 nanoparticles

Kai Zhang,Ying Zhao,Linlin Wang,Lili Zhao,Xiaochang Liu,Shaoheng He

DOI: https://doi.org/10.1016/j.inoche.2020.108277

IF: 3.428

2020-12-01

Inorganic Chemistry Communications

Abstract:Transdermal drug delivery system (TDDS) is a successful non-invasive drug delivery system that shows several advantages. However, dose depletion effects remain a major challenge for sustained release TDDS. This study aimed to develop a polyacrylamide-modified MoS2 nanoparticles (CPAM-MoS2 NPs) based TDDS, which could control drug release and prolong the treatment time by light stimulation. In this work, the CPAM-MoS2 were produced by a facile hydrothermal method. The structure of CPAM-MoS2 NPs was detected by using FTIR, XRD and TEM, and the surface morphololgy of the NPs was observed by SEM. The colloid stability was tested by zeta potential and sedimentation volume ratio. Moreover, In vivo skin erythema study was conducted to explore the biocompatibility of CPAM-MoS2 NPs. As a result, the synthesisezed colloid-stable and skin-safe CPAM-MoS2 NPs possessed a high drug load efficiency of 87.2% and excellent photothermal conversion efficiency that was successfully applied in a TDDS with an enhancement ratio of 1.82. We measured its controlled release ability in an in vitro skin penetration test and, moreover, no drug depletion was observed during the 8-hour study in the light stimulation group. This paper describes the first use of CPAM-MoS2 NPs as a carrier for drugs in a TDDS.

chemistry, inorganic & nuclear
Microneedle-Assisted Transfersomes as a Transdermal Delivery System for Aspirin

Raha Rahbari,Lewis Francis,Owen J Guy,Sanjiv Sharma,Christopher Von Ruhland,Zhidao Xia

DOI: https://doi.org/10.3390/pharmaceutics16010057

IF: 6.525

2023-12-29

Pharmaceutics

Abstract:Transdermal drug delivery systems offer several advantages over conventional oral or hypodermic administration due to the avoidance of first-pass drug metabolism and gastrointestinal degradation as well as patients' convenience due to a minimally invasive and painless approach. A novel transdermal drug delivery system, comprising a combination of transfersomes with either solid silicon or solid polycarbonate microneedles has been developed for the transdermal delivery of aspirin. Aspirin was encapsulated inside transfersomes using a "thin-film hydration sonication" technique, yielding an encapsulation efficiency of approximately 67.5%. The fabricated transfersomes have been optimised and fully characterised in terms of average size distribution and uniformity, surface charge and stability (shelf-life). Transdermal delivery, enhanced by microneedle penetration, allows the superior permeation of transfersomes into perforated porcine skin and has been extensively characterised using optical coherence tomography (OCT) and transmission electron microscopy (TEM). In vitro permeation studies revealed that transfersomes enhanced the permeability of aspirin by more than four times in comparison to the delivery of unencapsulated "free" aspirin. The microneedle-assisted delivery of transfersomes encapsulating aspirin yielded 13-fold and 10-fold increases in permeation using silicon and polycarbonate microneedles, respectively, in comparison with delivery using only transfersomes. The cytotoxicity of different dose regimens of transfersomes encapsulating aspirin showed that encapsulated aspirin became cytotoxic at concentrations of ≥100 μg/mL. The results presented demonstrate that the transfersomes could resolve the solubility issues of low-water-soluble drugs and enable their slow and controlled release. Microneedles enhance the delivery of transfersomes into deeper skin layers, providing a very effective system for the systemic delivery of drugs. This combined drug delivery system can potentially be utilised for numerous drug treatments.
In-situ fast gelling formulation for oral sustained drug delivery of paracetamol to dysphagic patients

Suraj Sharma,Gunjan Sarkar,Bhupendra Srestha,Dipankar Chattopadhyay,Manas Bhowmik

DOI: https://doi.org/10.1016/j.ijbiomac.2019.05.092

2019-08-01

Abstract:Evaluation of the potential for oral sustained drug delivery of formulations with in-situ gelling properties is the main objective of the present investigation. Oral administration of aqueous dispersion of sodium alginate (1.5% w/v) containing calcium ions in complex form resulted in the formation of gel matrix as a consequence of the release of the calcium ions in the acidic environment of stomach fluid. Addition of methylcellulose, sodium chloride and polyethylene glycol improved the drug retention efficacy of the gel. In this investigation, the study on the influence of added excipients on the rheological and drug release properties of the formulations has been focused. In-vitro studies demonstrated diffusion-controlled release of paracetamol from the gels. The bioavailability of orally administered paracetamol from the in-situ gel F4 (composed of 1.5% sodium alginate, 1.5% methyl cellulose, 3% CaCO3, 2% NaCl 0.05% polyethylene glycol) administered in the stomach of rabbit, was more sustained as compared to the commercially available suspension Calpol® containing an identical dose of paracetamol.
A comprehensive review on transdermal patches as an efficient approach for the delivery of drug

Ansa Ashfaq,Tehseen Riaz,Muhammad Ahsan Waqar,Muhammad Zaman,Imtiaz Majeed

DOI: https://doi.org/10.1080/25740881.2024.2317408

2024-02-21

Polymer-Plastics Technology and Materials

Abstract:In past years, various studies have considered transdermal drug delivery system for improving patient compliance. One approach to deliver drug via transdermal route is transdermal patch. These patches include single-layer drug in adhesive patches and micro reservoir transdermal patch & matrix system. Acrylic-acid, hydroxypropyl methylcellulose (HPMC) and polyethylene glycol are commonly used polymers for manufacturing of transdermal patches. Characterization of patches includes patch thickness, weight uniformity, irritation studies, in-vitro drug release and permeation studies. This review summarizes various polymers, types of transdermal patches and evaluation of transdermal patches based on up-to-date data extracted from reputed journals and official websites.

polymer science

Chronic eosinophilic leukaemia in blast crisis in a cat negative for feline leukaemia virus

Nanoparticle formulations as recrystallization inhibitors in transdermal patches

Transdermal Delivery of Curcumin-Loaded Solid Lipid Nanoparticles as Microneedle Patch: an In Vitro and In Vivo Study

Formulation and Characterization of Ethyl Cellulose-Based Patches Containing Curcumin-Chitosan Nanoparticles for the Possible Management of Inflammation via Skin Delivery

A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery

Role of the carboxyl terminus in stable expression of hamster UDP-GlcNAc:dolichol-P GlcNAc-1-P transferase.

Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study

Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol

Dissolvable microneedles for transdermal drug delivery showing skin pentation and modified drug release

Self-Nanoformulating Poly(2-oxazoline) and Poly(2-oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study

Porous microneedle arrays as promising tools for the quantification of drugs in the skin: a proof of concept study

Is the male Aicardi's characterized by 46 XXY karyotype?

Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.

Development of Piroxicam loaded SLN-based Hydrogel for Transdermal Delivery

Effect of HEC (Hydroxyethyl Cellulose) Polymer on Nanoemulsion-Based Curcumin Transdermal Patch Release

Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems

Nanosuspension-Based Drug Delivery Systems for Topical Applications

NIR-responsive transdermal delivery of atenolol based on polyacrylamide-modified MoS2 nanoparticles

Microneedle-Assisted Transfersomes as a Transdermal Delivery System for Aspirin

In-situ fast gelling formulation for oral sustained drug delivery of paracetamol to dysphagic patients

A comprehensive review on transdermal patches as an efficient approach for the delivery of drug